Former Head of Cellular Operations
This person is a member of Sanger Institute Alumni.
Chris Kirton has a background in molecular immunology and biopharmaceutical drug development, mainly antibodies and vaccines. Prior to joining the Sanger Institute Chris was a post-doc in the Division of Immunology at Cambridge University where he developed a monoclonal antibody against the inflammatory mediator VAP-1 and later became Head of the Cell Biology and Biopharmaceutical areas at ENVIGO, a global CRO.
Programmes and Facilities
Cancer, Ageing and Somatic Mutation
The Cancer, Ageing and Somatic Mutation Programme seeks to provide leadership in data aggregation and informatics innovation, developing high-throughput cellular ...
We are focused on using single-cell approaches, so called “cell atlas” technologies and understanding human genetics at the cellular level. The ...
The Infection Genomics Programme investigates the common underpinning mechanisms of evolution, infection and resistance to therapy in viruses, bacteria and ...